AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability. Explore Medical Science and Global Health, [S. l.], v. 3, p. 38–47, 2026. DOI: 10.70267/emsgh.v3.3847. Disponível em: https://journals.zeuspress.org/index.php/EMSGH/article/view/1628. Acesso em: 31 oct. 2026.